Not finding it? Sign in to also search OpenAlex live.
-
Daratumumab + bortezomib, thalidomide, and dexamethasone (D-VTd) in transplant-eligible newly diagnosed multiple myeloma (TE NDMM): Baseline SLiM-CRAB based subgroup analysis of CASSIOPEIA.2020 Journal of Clinical Oncology conference-abstract Medicine Multiple Myeloma Research and Treatments
Cyrille Touzeau, Philippe Moreau, Aurore Perrot, Cyrille Hulin, Mamoun Dib, Mourad Tiab, +13 more
8citations -
Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non‐germinal centre B‐cell‐like diffuse large B‐cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial
Jun Zhu, Xiaonan Hong, Yu Qin Song, Brendan Paul Hodkinson, Sriram Balasubramanian, Songbai Wang, +10 more
7citations -
Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone‐sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study2021 International Journal of Urology article Medicine Prostate Cancer Treatment and Research Open access
Taro Iguchi, Go Kimura, Satoshi Fukasawa, Hiroyoshi Suzuki, Hiroji Uemura, Kazuo Nishimura, +9 more
22citations -
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA2023 Annals of Hematology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kım, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, +16 more
13citations -
Subcutaneous Daratumumab (DARA SC) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Asian Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Subgroup Analysis from the Phase 3 Andromeda Study2020 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kım, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, +15 more
2citations -
Treatment Goals in Schizophrenia: Subgroup Analysis of a Survey in Matched Physician-Patient Pairs2025 Patient Preference and Adherence article Medicine Schizophrenia research and treatment Open access
Gerhard Gründer, Philipp Bauknecht, Stefanie Schell, Karolina Leopold, Michael Paulzen, Stefan Leucht
0citations -
How good are the outcomes of instrumented debulking operations for symptomatic spinal metastases and how long do they stand? A subgroup analysis in the global spine tumor study group database
Bart P. Depreitere, Federico Ricciardi, Mark P. Arts, Laurent Balabaud, Cody Eric Bünger, Jacob Maciej Buchowski, +17 more
25citations -
Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trial
Takashi Kadowaki, Guang Wang, Julio Rosenstock, Daisuke Yabe, Yongde Peng, Keizo Kanasaki, +6 more
16citations -
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer—a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial2025 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Malgorzata Joanna Banys-Paluchowski, Steffi Hartmann, Timo Basali, Maria Luisa Gasparri, Jana de Boniface, Oreste Gentilini, +37 more
6citations -
Asian Subgroup Analysis of the REMISSIO Study: A Long-Term Efficacy and Safety Study of Paliperidone Palmitate 3-month Formulation in Patients with Stable Schizophrenia in a Naturalistic Clinical Setting2022 Clinical Psychopharmacology and Neuroscience article Medicine Schizophrenia research and treatment Open access
Young‐Chul Chung, Yen Kuang Yang, Ahmad Hatim Sulaiman, Paul Bergmans
5citations -
MM-350: Daratumumab (DARA) + Lenalidomide/Bortezomib/Dexamethasone (RVd) in African American/Black Patients (Pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of GRIFFIN2020 Clinical Lymphoma Myeloma & Leukemia conference-abstract Medicine Multiple Myeloma Research and Treatments
Ajay K. Nooka, Jonathan L. Kaufman, Cesar Rodriguez, Andrzej J. Jakubowiak, Leyla Osman Shune, Ashraf Z. Badros, +8 more
3citations -
Navigating parenthood and a partner’s terminal cancer: subgroup analysis of the course of psychological distress within a comprehensive support program for families with parental cancer (Family-SCOUT)
L. Eggert, Barbara Drueke, Rebecca Bremen, Franziska Geiser, Lina Heier, Christoph Heuser-Loy, +6 more
0citations -
Post Hoc Analysis of the Effect of Pegcetacoplan Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria and Baseline Hemoglobin Levels Greater Than 10 Grams per Deciliter2021 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Jens Panse, Nicolas Daguindau, Sonia Okuyama, Régis Peffault de Latour, Philippe Schafhausen, Nicole Straetmans, +5 more
1citations